InsiderClue
Insiders · Profile

WEAVER GREGORY L

Chief Financial Officer at Altimmune · Former EVP, CFO, & Director at ATOSSA THERAPEUTICS · Chief Financial Officer at Eloxx Pharmaceuticals · and 1 more. Filing since 23 Feb 2007. CIK 0001251779

ALT Altimmune, Inc. Chief Financial Officer · 3 trades ATOS ATOSSA THERAPEUTICS, INC. Former EVP, CFO, & Director · 4 trades ELOX Eloxx Pharmaceuticals, Inc. Chief Financial Officer · 1 trade IMNN Imunon, Inc. CFO · 5 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ALT Altimmune, Inc.
1 Apr 2026
Chief Financial Officer
Bought
10,000
$31.50K
35.6%
ALT Altimmune, Inc.
6 Mar 2026
Chief Financial Officer
Bought
5,000
$17.70K
21.7%
ALT Altimmune, Inc.
13 Mar 2025
Chief Financial Officer
Bought
10,000
$52.00K
opened
ATOS ATOSSA THERAPEUTICS, INC.
15 Nov 2023
Former EVP, CFO, & Director
Sold at will
50,000
$32.50K
99.9%
ATOS ATOSSA THERAPEUTICS, INC.
20 Jun 2023
EVP & CFO
Bought
50,000
$48.50K
×909
ATOS ATOSSA THERAPEUTICS, INC.
2 Jul 2021
Director
Sold, plan not stated
107,497
$599.83K
100%
ELOX Eloxx Pharmaceuticals, Inc.
23 Mar 2018
Chief Financial Officer
Bought
4,500
$38.52K
opened
ATOS ATOSSA THERAPEUTICS, INC.
21 Nov 2013
Director
Bought
10,000
$25.79K
40.8%
IMNN Imunon, Inc.
19 Mar 2013
CFO
Sold, plan not stated
37,272
$39.51K
100%
IMNN Imunon, Inc.
6 Dec 2011
CFO
Bought
5,000
$10.75K
21.2%
IMNN Imunon, Inc.
26 May 2011
Director
Bought
8,636
$23.92K
57.6%
IMNN Imunon, Inc.
16 Sep 2010
Director
Bought
5,000
$15.50K
50.0%
IMNN Imunon, Inc.
23 Feb 2007
Director
Bought
10,000
$35.00K
opened
13 decisions on file.